EB1 (Consular Processing), Alessandra Kurahashi Dantas, 3685

715

300

Petition Cover Sheet

G-1145, E-Notification of Application/Petition Acceptance

Form G-28: Notice of Entry of Appearance as Attorney or Accredited Representative

Form I-140: Immigrant Petition for Alien Worker

Petition Cover Letter

A.1. Dr. Dantas’ Personal Statement.

A.2. Dr. Dantas’ Resume.

A.3. Diploma of Physician and school transcripts – Federal University of Parana.

A.4. Certificate of completion medical residency in Ophthalmology – State University of Campinas.

A.5. Specialist certification in ophthalmology – Brazilian Medical Association (AMB).

A.6. Certificate - Specialization in Quantum Biophysics and Bioresonance Applied to Health - Cieph school of health technology.

A.7. Certificate of completion Specialization Program in Integrative Medicine – FACONNECT.

A.8. Certificate of completion Advanced Oculofacial Surgery Course 2026 – University of California, San Diego School of Medicine.

A.9. Acceptance email as International Associate Member with the American Society of Ophthalmic Plastic and Reconstructive Surgery – ASOPRS.

A.10. Eye Health Data and Statistics, Nat’l Eye Inst., Nat’l Insts. of Health, U.S. Dep’t of Health & Hum. Servs., https://www.nei.nih.gov/about/education-and-outreach/eye-health-data-and-statistics.

A.11. United States Medical Licensing Examination (USMLE) Step 1 Scheduling Permit issued by the Federation of State Medical Boards (FSMB), evidencing Dr. Dantas’ active pursuit of U.S. medical licensure and concrete steps toward continuing her professional activities and contributions in the United States healthcare sector.

B.1. Certificate of membership as a full member, the Brazilian Society of Oculoplastic Surgery, demonstrating that Dr. Dantas is a member within the society since 2018.

B.2. Letters of recommendation written by national experts that supported her application back in 2018, demonstrating that SBCPO’s membership requires outstanding achievements.

B.3. Sections of SBCPO’s which clearly demonstrate that the society requires outstanding achievements to be admitted as a full member.

B.4. Expert Opinion Letter from Patricia Mitiko Santello Akaishi, M.D., Former President, Sociedade Brasileira de Cirurgia Plástica Ocular (SBCPO), explaining SBCPO membership standards and expert evaluation requirements for Full Membership.

B.5. Printout Become a Member of SBCPO, Sociedade Brasileira de Cirurgia Plástica Ocular (SBCPO), https://sbcpo.org.br, demonstrating that the Society requires outsanting achievements of its members as judged by experts.

B.6. SBCPO Deliberative Council information, demonstrating that the professionals that judge the applications for membership are recognized national experts in the field.

B.7. ASOPRS acceptance email, dated April 26, 2026, demonstrating that Dr. Dantas is a current International Associate Member within the international association.

B.8. Printout from the American Society of Ophthalmic Plastic and Reconstructive Surgery official website, “About ASOPRS,” describing the organization’s mission dedicated to education, research, and quality of clinical practice in oculofacial plastic surgery.

B.9. Copy of Dr. Dantas’ application within ASOPRS including support letters and ongoing emails, demonstrating that the association requires outstanding achievements of its members.

B.10. Printout from ASOPRS official membership page for International Associate status, submitted to demonstrate that this level of membership requires distinguished professional qualifications and expert review.

B.11. Printout from ASOPRS official webpage for the Membership Committee, stating that the Committee’s purpose is to oversee the membership entry process and review membership applications with recommendations to the Board, and further stating that committee members must be ASOPRS members for a minimum of ten years, submitted to demonstrate that admissions decisions are made by recognized experts in the field.

B.12. Resume of Edward J. Wladis, M.D., F.A.C.S., identified by ASOPRS as the Membership Director and Chair of the Membership Committee, submitted to demonstrate that ASOPRS membership applications are evaluated by recognized experts in ophthalmic plastic and reconstructive surgery.

C.1. Screenshot and transcript of Band Mulher 12/17/2025, featuring Dr. Alessandra Kurahashi Dantas discussing blepharoplasty and ophthalmology, published by Band Campinas on YouTube, https://www.youtube.com/watch?v=qShR1EyFjIs (Dec. 17, 2025), demonstrating published material about Dr. Dantas and her work.

C.2. Printout of Band Campinas official programming schedule showing Band Mulher – Campinas as a regularly scheduled weekday television program airing at 11:30 a.m., published on the official Band website, Band Campinas – Full Programming, demonstrating that the publication qualifies as a major media publication.

C.3. Screenshot of the official Band Campinas YouTube channel showing channel metrics, including approximately 91,900 subscribers, 32,387 uploaded videos, and 20,312,934 cumulative views, demonstrating substantial digital audience reach and viewership, consistent with a major media publication available at https://www.youtube.com/@BandtvCampinas.

C.4. Printout of independent web analytics for Band TV’s official website, band.com.br, showing approximately 4.683 million monthly worldwide visits in March 2026, corroborating the national reach, audience engagement, and standing of the Band network brand as a major media publication.

C.5. Screenshot and transcript of THA WITH EVERYTHING – LIVE (Tha Com Tudo), featuring Dr. Dantas discussing eye health, ophthalmology, and specialized treatment of ocular conditions, published by TH+ Record on YouTube, https://www.youtube.com/watch?v=aHatsz7sFQE (May 12, 2025), demonstrating published material about Dr. Dantas and her professional work.

C.6. Screenshot of the official TH+ Record YouTube channel showing channel metrics, including approximately 18,900 subscribers, 1,935 uploaded videos, and 13,275,621 cumulative views, demonstrating substantial digital audience reach and viewership consistent with a major video publication.

C.7. Printout of independent web analytics for Record TV’s official digital platform, record.r7.com, showing approximately 2.992 million monthly worldwide visits in March 2026, corroborating the national reach, audience engagement, and standing of the Record network brand as a major media publication.

D.1. E-mail from Prof. Rodrigo Lira, Assoc. Ed., Arquivos Brasileiros de Oftalmologia, to Dr. Alessandra Dantas (Oct. 9, 2025, 15:07 BRT), inviting Dr. Dantas to peer-review Manuscript ID ABO-2025-0287, Performance Analysis of AI-Based Tools for Diabetic Retinopathy Detection in a Primary Care Setting, and thereby evidencing her invitation to judge the work of others in her field of extraordinary ability.

D.2. E-mail from Prof. Rodrigo Lira, Assoc. Ed., Arquivos Brasileiros de Oftalmologia, to Dr. Alessandra Dantas (Oct. 10, 2025, 09:38 BRT), acknowledging Dr. Dantas's acceptance of the invitation to review Manuscript ID ABO-2025-0287 and confirming access to the journal's Reviewer Center.

D.3. E-mail from Conselho Brasileiro de Oftalmologia, via Web of Science (Clarivate), to Dr. Alessandra Dantas (Oct. 12, 2025, 10:31 BRT), offering Web of Science recognition for her completed peer review of Performance Analysis of AI-Based Tools for Diabetic Retinopathy Detection in a Primary Care Setting, thereby confirming her participation as a reviewer.

D.4. E-mail from Prof. Rodrigo Lira, Assoc. Ed., Arquivos Brasileiros de Oftalmologia, to Dr. Alessandra Dantas (Oct. 12, 2025), confirming submission of Dr. Dantas's completed review of Manuscript ID ABO-2025-0287 and thereby demonstrating that she actually performed the peer evaluation.

D.5. Arquivos Brasileiros de Oftalmologia, About, https://www.aboonline.org.br/about establishing that ABO is a peer-reviewed ophthalmology journal published continuously since 1938 by the Brazilian Council of Ophthalmology, indexed in Web of Science, PubMed/MEDLINE, SCOPUS, EMBASE, SciELO, and LILACS, with a 2025 Impact Factor of 1.029, thereby demonstrating the reputability and trustworthiness of the publication and confirming that its scope falls squarely within Dr. Dantas's field of extraordinary ability.

E.1. Original copy of “Protocol for access and risk assessment in ophthalmology”, from city of Campinas, dated November 2011, listing Dr. Dantas as a member of the working group 2004, demonstrating that she made an original contribution to her field.

E.2. Original copy of “Protocol for access and risk assessment in ophthalmology”, from city of Campinas, 2024 edition, listing Dr. Dantas as a member of the working group review - 2022, demonstrating that she made an original contribution to her field.

E.3. Official statement from City of Campinas, dated December 16, 2025, declaring that Dr. Dantas participated in the preparation of the Ophthalmology Protocol - Access and Risk Assessment of the Municipal Health Secretariat in the year 2004, demonstrating that she made original contributions.

E.4. Copy of Decree No. 20,044 of October 9, 2018 (municipal ordinance), establishing “Outubro Brilhante” (“Bright October”) and Cataract Blindness Prevention Week, expressly recognizing the existence of the Protocol for Access and Risk Assessment for the ophthalmology specialty to organize referrals and guarantee priority access for preventable blindness cases, submitted to demonstrate the long-standing governmental adoption and major public-health impact of the ophthalmology risk assessment framework to which Dr. Dantas contributed.

E.5. The State Health Department of Espírito Santo entitled Protocolo Gestão da Clínica e Regulação Formativa – Especialidade Oftalmologia (2020/2021), listing in its bibliographic references the Campinas Protocol for Access and Risk Assessment in Ophthalmology, submitted to demonstrate that the ophthalmology risk assessment framework to which Dr. Dantas contributed was relied upon as an authoritative reference by another Brazilian state jurisdiction, thereby evidencing replication, external recognition, and major impact in the field.

E.6. Institution declaration of public health impact from the city of Campinas Health Department, stating that Dr. Dantas’ program has been continuously implemented throughout the entire public health system of Campinas since 2018, benefits thousands of children annually, particularly vulnerable populations, and has achieved significant population-level impact in the prevention of avoidable blindness and promotion of eye health, therefore demonstrating major impact.

E.7. Printout of official Campinas municipal news article titled Outubro Brilhante: ação especial reúne 3,4 mil vagas para atendimentos oftalmológicos gratuitos (Oct. 1, 2025), reporting that the public-health campaign provided hundreds of free ophthalmologic appointments, pediatric services, diagnostic testing, and eyeglasses for children and teenagers, submitted to demonstrate the substantial public-health reach and measurable impact of a blindness-prevention initiative developed from the ophthalmology access and risk assessment framework to which Dr. Dantas contributed.

E.8. Printout of media article titled Campinas zera demanda reprimida de consultas oftalmológicas, diz Saúde (Oct. 6, 2025), highlighting the role of Outubro Brilhante and reorganized ophthalmologic care pathways, submitted to demonstrate recognized, measurable, and population-level impact of the ophthalmology system and related initiatives associated with Dr. Dantas’ work.

F.1. Copy of the scholarly article titled The effects of a single dose of sildenafil citrate (Viagra®) on the retrobulbar circulation and visual field, published in Arquivos Brasileiros de Oftalmologia, identifying Dr. Alessandra Kurahashi Dantas as a co-author, submitted to demonstrate her authorship of a scholarly article in the field of ophthalmology.

F.2. Official website information from Arquivos Brasileiros de Oftalmologia “Instructions to Authors” webpage describing accepted manuscript types, including original clinical and scientific studies requiring methodological rigor, structured format, and compliance with international publication standards, submitted to demonstrate that the journal qualifies as a professional, peer-reviewed publication directed to a learned audience in the field of ophthalmology.

F.3. Certificates of Poster Presentations the XXIX Brazilian Congress of Ophthalmology, dated September 1997, demonstrating that Dr. Dantas is the author of Published conference presentations at nationally recognized conferences.

F.4. Printout of the Brazilian Council of Ophthalmology (CBO) Guidelines for Submitting Free Themes and Case Reports for the Brazilian Congress of Ophthalmology, detailing that submitted works must be original, follow structured scientific formats (including objective, method, results, and conclusion), and are subject to review and potential rejection by a Scientific Committee based on criteria such as methodological rigor and scientific contribution, submitted to demonstrate that conference presentations are formally evaluated and constitute scholarly works presented within a recognized professional scientific forum.

G.1. Certificate of participation as Lecturer at the XXXII Brazilian Congress of Ophthalmology, held in Salvador, Bahia, Brazil, from September 10–13, 2003, where Petitioner presented “Study of 305 Cases of Chronic Dacryocystitis” in the course on Infectious Diseases of the Lacrimal Pathways, organized by the Brazilian Council of Ophthalmology (CBO).

G.2. Certificate of participation as Lecturer at the XV Brazilian Congress on Prevention of Blindness and Visual Rehabilitation, held in Curitiba, Paraná, Brazil, from August 31 to September 3, 2002, where Petitioner presented “Study of Chronic Dacryocystitis in 350 Cases” in Symposium I on Infectious Diseases of the Lacrimal Pathways, organized by the Brazilian Council of Ophthalmology (CBO).

G.3. Certificate of participation as Lecturer at the X SINCLIO – International Symposium on Cataract and Intraocular Lens (Pre-Congress Course), held in Campinas, Brazil, from March 7–10, 2005, where Petitioner delivered a lecture on “Lacrimal Pathways,” organized by the UNICAMP Ophthalmology Seminar.

G.4. Certificate of participation as Lecturer at the XI International Symposium on Cornea and Contact Lenses, held in São Paulo, Brazil, on March 26, 2004, where Petitioner lectured on “Dacryocystorhinostomy” in the course on Loco-regional Anesthesia, organized by the UNICAMP Ophthalmology Seminar.

G.5. Certificate of participation as Lecturer at the XI International Symposium on Cornea and Contact Lenses (Pre-Symposium), held in São Paulo, Brazil, on March 25, 2004, where Petitioner lectured on “Use in Ophthalmology” within the course “The Daily Practice of the Ophthalmologist – Ocular Plastic Surgery,” organized by the UNICAMP Ophthalmology Seminar.

G.6. Certificate of participation as Lecturer at the VI International Symposium on Cataract and Intraocular Lens, held in São Paulo, Brazil, from March 20–22, 1998, where Petitioner presented “Eye Drops Most Commonly Used in Ophthalmology” in the Course for Ophthalmologist Assistants.

G.7. Certificate of participation as Lecturer at the Ophthalmology Update Course held at the School of Medical Sciences of UNICAMP, Campinas, Brazil, on October 18, 2003, where Petitioner lectured in the Ocular Plastic Surgery Symposium, organized by the Department of Ophthalmology of UNICAMP.

G.8. Certificate of participation as Lecturer at the II Ophthalmology Update Course, held in Campinas, Brazil, on October 16, 2004, where Petitioner presented “Differential Diagnosis of the Red Eye” in the Emergency in Ophthalmology Course, organized by the Department of Ophthalmology of UNICAMP.

H.1. Amendment to the Partnership Agreement of Nova Campinas Oftalmologia further evidencing Petitioner’s continued leadership role and expanded responsibilities within the organization.

H.2. Nova Campinas registration – Brazilian National Register of Legal Entities.

H.3.Official Clinical Staff (“Corpo Clínico”) documentation of Nova Campinas Oftalmologia identifying Petitioner as a leading physician within the institution, confirming her senior position in the organization’s professional structure.

H.4. Letter from Denise Fornazari de Oliveira, attesting to Petitioner’s leadership role, professional standing, and significant contributions within Nova Campinas Oftalmologia.

H.5. Official Statement from Nova Campinas Oftalmologia, signed by André Flores, certifying the institution’s 25-year history of operations, its substantial patient volume of approximately 16,000 consultations and 800 surgeries annually, and its consistent 5% annual growth rate, demonstrating its distinguished reputation.

H.6. Printout from the Brazilian National Registry of Health Establishments (CNES/DATASUS) listing Andre Corio Flores as an Administrator affiliated with Nova Campinas Oftalmologia, including his active status and role within the organization, submitted to demonstrate his official position and competence to provide a statement regarding the clinic’s operations with elements sufficient to support its distinguished reputation.

I.1. Certified statement from Petitioner’s accountant, Edivalmir Antonio Massa, attesting to Petitioner’s remuneration derived from her activities as a partner in Nova Campinas Oftalmologia Ltda. and Dantas Oftalmologia Ltda., as well as her salary as a public employee physician, including detailed revenue figures for 2023, 2024, and 2025.

I.2. Corporate tax filing (ECF) for Nova Campinas Oftalmologia Ltda. for the 2024 fiscal year, documenting the company’s gross revenue and corroborating Petitioner’s substantial remuneration derived from her role as a partner.

I.3. Corporate tax filing (ECF) for Nova Campinas Oftalmologia Ltda. for the 2023 fiscal year, further evidencing consistent and significant revenue generation attributable to Petitioner’s professional activities.

I.4. Official income statement from the City of Campinas reflecting Petitioner’s salary as a government-employed ophthalmologist, including her annual compensation.

I.5. Copy of Dr. Dantas’ foreign federal income tax return.

I.6. Industry compensation data for ophthalmologists in Brazil, demonstrating that Petitioner’s remuneration is substantially higher than that of other professionals working in the same field.

J.1. State Council of Medicine in Sao Paulo Certificate of recognition for 25 years of practice to Dr. Dantas;

J.2. Certificates of participation as a coordinator for national congresses and conferences in her field.

J.3. Other relevant digital media publications about Dr. Dantas’ work not classified as major media – radio, regional magazines, and youtube channels.

J.4. Evidence of recognition and trust – certificate of voluntary work performed by Dr. Dantas in her field.

J.5. Certificate of collaborator in the health week from the Union of Gakusseis in Curitiba, Brazil.

J.6. Declaration from the Ophthalmology Department, School of Medical Sciences (FCM/UNICAMP), certifying that Dr. Dantas conducted a lecture on “Antibiotics and Antivirals” (May 20, 1997).

J.7. Certificate from the Federal University of Paraná confirming that Dr. Dantas received the “Professor Nilo Cairo” Academic Award for ranking first in the Medicine program and achieving the highest overall academic performance (Jan. 22, 1996).

J.8. Certificate of recognition from the Brazilian Council of Ophthalmology for Dr. Alessandra Kurahashi Dantas’ participation in the National Visual Rehabilitation Campaign “Eye to Eye” (2001).

J.9. Declaration from the Department of Ophthalmology, Clinical Hospital of UNICAMP, confirming Dr. Alessandra Kurahashi Dantas’ participation in the “Meninas dos Olhos de Atibaia” blindness prevention program (Sept. 27, 2025).

J.10. Letter of Support from Maria Augusta Montenegro, PhD.

J.11. Letter of Support from Carlos Eduardo Leite Arieta, PhD.

J.12. Letter of Support from Jeremiah Tao, MD.

J.13. Letter of Support from Pablo Cibils, MD.

J.14. Letter of Support from Cintia de Paiva, MD.

J.15. Dr. Dantas’ personal documents

J.16. Derivative beneficiary’s personal documents.